Competition law and pricing among biologic drugs: the case of VEGF therapy for retinal diseases

Neovascular age-related macular degeneration (AMD) is a progressive eye disease and is a leading cause of vision loss in the Western world. Vascular endothelial growth factor inhibitors have become a mainstay of treatment for this disease. Currently, treatment options include three originator biolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Van de Wiele, Victor L, Hammer, Maximilian, Parikh, Ravi, Feldman, William B, Sarpatwari, Ameet, Kesselheim, Aaron S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863367/
https://www.ncbi.nlm.nih.gov/pubmed/35211322
http://dx.doi.org/10.1093/jlb/lsac001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863367/
https://www.ncbi.nlm.nih.gov/pubmed/35211322
http://dx.doi.org/10.1093/jlb/lsac001

Ejemplares similares